摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-iodo-1H-benz[d][1,3]oxazine-2,4-dione | 115081-94-2

中文名称
——
中文别名
——
英文名称
7-iodo-1H-benz[d][1,3]oxazine-2,4-dione
英文别名
7-Jod-1H-benz[d][1,3]oxazin-2,4-dion;7-iodo-2H-3,1-benzoxazine-2,4(1H)-dione;4-iodoisatoic anhydride;7-Iodo-1H-benzo[d][1,3]oxazine-2,4-dione;7-iodo-1H-3,1-benzoxazine-2,4-dione
7-iodo-1<i>H</i>-benz[<i>d</i>][1,3]oxazine-2,4-dione化学式
CAS
115081-94-2
化学式
C8H4INO3
mdl
——
分子量
289.029
InChiKey
AMFXDGWSUCLGET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    7-iodo-1H-benz[d][1,3]oxazine-2,4-dionesodium hydroxide 作用下, 以 甲醇 为溶剂, 以80%的产率得到2-氨基-4-吲哚苯甲酸甲酯
    参考文献:
    名称:
    Pyridazinedione compounds useful in treating neurological disorders
    摘要:
    本发明涉及吡啶并[4,5-b]喹啉及其药用盐,它们是兴奋性氨基酸拮抗剂,在需要此类拮抗作用时非常有用,例如在治疗神经系统疾病时。该发明还提供含有吡啶并[4,5-b]喹啉作为活性成分的药物组合物,以及治疗神经系统疾病的方法。
    公开号:
    US05599814A1
  • 作为产物:
    描述:
    6-碘靛红乙酸酐 作用下, 以 溶剂黄146 为溶剂, 以81.8%的产率得到7-iodo-1H-benz[d][1,3]oxazine-2,4-dione
    参考文献:
    名称:
    Pyridazinedione compounds useful in treating neurological disorders
    摘要:
    本发明涉及吡啶并[4,5-b]喹啉及其药用盐,它们是兴奋性氨基酸拮抗剂,在需要此类拮抗作用时非常有用,例如在治疗神经系统疾病时。该发明还提供含有吡啶并[4,5-b]喹啉作为活性成分的药物组合物,以及治疗神经系统疾病的方法。
    公开号:
    US05599814A1
点击查看最新优质反应信息

文献信息

  • [EN] MODIFIED PROTEINS AND PROTEIN DEGRADERS<br/>[FR] PROTÉINES MODIFIÉES ET AGENTS DE DÉGRADATION DE PROTÉINES
    申请人:CULLGEN SHANGHAI INC
    公开号:WO2021239117A1
    公开(公告)日:2021-12-02
    Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
    本文提供了结合或降解靶蛋白的化合物、药物组合物和方法。本文还提供了具有DNA损伤结合蛋白1(DDB1)结合基团的化合物。其中一些实施例包括连接物。其中一些实施例包括靶蛋白结合基团。本文还提供了配体-DDB1复合物。本文还提供了体内修饰的DDB1蛋白。
  • Pyridazinedione compounds useful in the treating neurological disorders
    申请人:Imperial Chemical Industries PLC
    公开号:US05733910A1
    公开(公告)日:1998-03-31
    The present invention relates to pyridazino\x9b4,5-b!quinolines, and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is desired such as in the treatment of neurological disorders. The invention further provides pharmaceutical compositions containing pyridazino\x9b4,5-b!quinolines as active ingredient, and methods for the treatment of neurological disorders.
    本发明涉及吡啶并[4,5-b]喹啉及其药用盐,其为兴奋性氨基酸拮抗剂,在需要这种拮抗作用时,如治疗神经系统疾病时,具有有用性。本发明还提供含有吡啶并[4,5-b]喹啉作为活性成分的制药组合物,以及治疗神经系统疾病的方法。
  • Pyridazinediones and their use in the treatment of neurological disorders
    申请人:ZENECA LIMITED
    公开号:EP0516297A1
    公开(公告)日:1992-12-02
    The present invention relates to pyridazino[4,5-b]quinolines, and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is desired such as in the treatment of neurological disorders. The invention further provides pharmaceutical compositions containing pyridazino[4,5-b]quinolines as active ingredient, and methods for the treatment of neurological disorders.
    本发明涉及哒嗪并[4,5-b]喹啉、 及其药用盐,它们是兴奋性氨基酸拮抗剂,在治疗神经系统疾病等需要这种拮抗剂时非常有用。本发明进一步提供了含有哒嗪并[4,5-b]喹啉类活性成分的药物组合物,以及治疗神经系统疾病的方法。
  • Nonaqueous electrolyte solution for secondary batteries and secondary battery provided with same
    申请人:STELLA CHEMIFA CORPORATION
    公开号:US11005125B2
    公开(公告)日:2021-05-11
    A nonaqueous electrolytic solution for a secondary battery exhibits excellent cycle characteristics even in high-temperature environments. The solution includes at least one of boric acid esters, acid anhydrides, cyclic carbonates having an unsaturated bond, cyclic carbonates having a halogen atom, cyclic sulfonic acid esters, and amines having an acetoacetyl group. A secondary battery having a positive electrode and a negative electrode makes use of this electrolytic solution.
    一种用于二次电池的非水性电解溶液,即使在高温环境下也能表现出优异的循环特性。该溶液包括硼酸酯、酸酐、具有不饱和键的环状碳酸盐、具有卤素原子的环状碳酸盐、环状磺酸酯和具有乙酰乙酰基的胺中的至少一种。具有正极和负极的二次电池可使用这种电解溶液。
  • Synthesis and nematicidal activities of 1,2,3-benzotriazin-4-one containing 4,5-dihydrothiazole-2-thiol derivatives against <i>Meloidogyne incognita</i>
    作者:Xiulei Chen、Zhen Zhou、Zhong Li、Xiaoyong Xu
    DOI:10.1080/10426507.2019.1661413
    日期:2020.3.3
    A series of novel 1,2,3-benzotriazin-4-one derivatives containing 4,5-dihydrothiazole-2-thiol were synthesized and characterized by H-1 NMR, C-13 NMR, F-19 NMR and HRMS. The bioassay results showed that compounds 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-7-methoxybenzo[d][1-3]triazin-4(3H)-one, 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-6-nitrobenzo[d][1-3]triazin-4(3H)-one, 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1-3]triazin-4(3H)-one exhibited good control efficacy against the cucumber root-knot nematode disease caused by Meloidogyne incognita at the concentration of 10.0 mg L-1 in vivo. Compound 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1-3]triazin-4(3H)-one showed excellent nematicidal activity with inhibition 68.3% at a concentration of 1.0 mg L-1. It suggested that the structure of 1,2,3-benzotriazin-4-one containing 4,5-dihydro-thiazole-2-thiol could be optimized further.
查看更多